Lin, Gen-Min <br/><br/>
Pexelizumab, an Anti-C5 Complement Antibody for Primary Coronary Revascularization: A New Insight from Old Versions.  [electronic resource] 

 -  Cardiovascular & hematological disorders drug targets  2011 
 - 97-101 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2212-4063 
<br/><br/><label>Standard No.: </label>10.2174/187152911798347043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Complement C5--antagonists & inhibitors<br/>Humans<br/>Myocardial Infarction--drug therapy<br/>Percutaneous Coronary Intervention--methods<br/>Single-Chain Antibodies--administration & dosage<br/>Treatment Outcome